EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)
| 6.28 Delayed Data As of 3:59pm ET |  +0.19 / +3.12%Today’s Change | 2.19 Today|||52-Week Range 15.63 | +79.43% Year-to-Date |
Latest EYPT News | Press Releases
| Does EyePoint Pharmaceuticals (EYPT) Have the Potential to Rally 336.07% as Wall Street Analysts Expect? Nov 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.09 |
| Today’s open | 6.32 |
| Day’s range | 6.22 - 6.62 |
| Volume | 18,573 |
| Average volume (3 months) | 550,626 |
| Market cap | $217.5M |
Data as of 3:59pm ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -34.90% |
| Earnings growth (this year) | +82.92% |
| Earnings growth (next 5 years) | +31.90% |
| Revenue growth (last year) | +12.09% |
| P/E ratio | NM |
| Price/Sales | 3.15 |
| Price/Book | 2.18 |
Financials
| Next reporting date | February 29, 2024 |
| EPS forecast (this quarter) | -$0.71 |
| Annual revenue (last year) | $41.4M |
| Annual profit (last year) | -$102.3M |
| Net profit margin | -246.97% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
